|
Zoe Lofgren
|
house |
glaxoSmithKline PLC (gSK) |
GSK |
STOCK |
Sale
|
Aug. 30, 2018 |
$$1,001 - $15,000 |
Sept. 13, 2018 |
|
Virginia Foxx
|
house |
glaxosmithKline PlC (gsK) |
GSK |
STOCK |
Purchase
|
April 12, 2018 |
$$1,001 - $15,000 |
May 10, 2018 |
|
Greg Gianforte
|
house |
JT GlaxoSmithKline PlC (GSK) |
GSK |
STOCK |
Purchase
|
March 26, 2018 |
$$1,001 - $15,000 |
April 13, 2018 |
|
Katherine M. Clark
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Sale
|
Jan. 3, 2018 |
$$1,001 - $15,000 |
Feb. 14, 2018 |
|
Katherine M. Clark
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Sale
|
Jan. 3, 2018 |
$$1,001 - $15,000 |
Feb. 14, 2018 |
|
Greg Gianforte
|
house |
GlaxoSmithKline PLC (GSK) |
GSK |
STOCK |
Sale
|
Dec. 14, 2017 |
$$50,001 - $100,000 |
Jan. 4, 2018 |
|
Kenneth R. Buck
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
S
|
Nov. 7, 2017 |
$$1,001 - $15,000 |
Dec. 11, 2017 |
|
Kenneth R. Buck
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
Oct. 27, 2017 |
$$1,001 - $15,000 |
Nov. 2, 2017 |
|
Virginia Foxx
|
house |
glaxosmithKline PlC (gsK) |
GSK |
STOCK |
Purchase
|
Oct. 25, 2017 |
$$1,001 - $15,000 |
Nov. 8, 2017 |
|
Pete Sessions
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
P
|
Oct. 25, 2017 |
$$1,001 - $15,000 |
Oct. 25, 2017 |
|
Virginia Foxx
|
house |
glaxosmithKline PlC (gsK) |
GSK |
STOCK |
Purchase
|
Oct. 24, 2017 |
$$1,001 - $15,000 |
Nov. 8, 2017 |
|
Pete Sessions
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
S
|
Aug. 31, 2017 |
$$1,001 - $15,000 |
Aug. 31, 2017 |
|
Virginia Foxx
|
house |
glaxosmithKline PlC (gsK) |
GSK |
STOCK |
Purchase
|
Aug. 4, 2017 |
$$15,001 - $50,000 |
Sept. 1, 2017 |
|
John Rutherford
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
July 11, 2017 |
$$1,001 - $15,000 |
Aug. 20, 2018 |
|
Zoe Lofgren
|
house |
glaxoSmithKline PLC (gSK) |
GSK |
STOCK |
Purchase
|
June 15, 2017 |
$$1,001 - $15,000 |
July 18, 2017 |
|
Charlie Joseph Crist
|
house |
glaxoSmithKline PLC (gSK) |
GSK |
STOCK |
Sale
|
Feb. 22, 2017 |
$$50,001 - $100,000 |
March 23, 2017 |
|
Pete Sessions
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
Dec. 1, 2016 |
$$1,001 - $15,000 |
May 1, 2017 |
|
Katherine M. Clark
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
Oct. 11, 2016 |
$$1,001 - $15,000 |
May 25, 2017 |
|
Katherine M. Clark
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
Oct. 11, 2016 |
$$1,001 - $15,000 |
May 25, 2017 |
|
E. Scott Rigell
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
March 8, 2016 |
$$15,001 - $50,000 |
April 28, 2016 |
|
Virginia Foxx
|
house |
glaxosmithKline PlC (gsK) |
GSK |
STOCK |
P
|
Feb. 11, 2016 |
$$15,001 - $50,000 |
March 7, 2016 |
|
Thomas MacArthur
|
house |
glaxoSmithKline PLC (gSK) |
GSK |
STOCK |
Sale
|
May 27, 2015 |
$$1,001 - $15,000 |
June 7, 2015 |
|
K. Michael Conaway
|
house |
glaxosmithKline PLC (gsK) |
GSK |
STOCK |
Sale
|
April 27, 2015 |
$$1,001 - $15,000 |
May 5, 2015 |
|
James B. Renacci
|
house |
GLAXOSMITHKLINE PLURISPOSED ADR (UNITED KINGDOM) (GSK) |
GSK |
STOCK |
Purchase
|
Oct. 23, 2014 |
$$1,000 - $15,000 |
Nov. 10, 2014 |
|
Thomas J. Rooney
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Sale
|
July 29, 2014 |
$$1,001 - $15,000 |
Jan. 16, 2017 |